The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer´s disease model mice
ABSTRACT: Alzheimer’s disease (AD) is the most common senile dementia in the world. Although important progress has been made in understanding the pathogenesis of AD, current therapeutic approaches provide only modest symptomatic relief. In this study, we evaluated the neuroprotective effect of quer...
- Autores:
-
Sabogal Guáqueta, Angélica María
Muñoz Manco, Juan Ignacio
Ramírez Pineda, José Robinson
Lamprea Rodríguez, Marisol
Osorio Durango, Edison
Cardona Gómez, Gloria Patricia
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2015
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/36475
- Acceso en línea:
- https://hdl.handle.net/10495/36475
- Palabra clave:
- Envejecimiento
Aging
Enfermedad de Alzheimer
Alzheimer Disease
Péptidos beta-Amiloides - metabolismo
Amyloid beta-Peptides - metabolism
Antioxidantes - uso terapéutico
Antioxidants - therapeutic use
Brain
Encéfalo
Trastornos del Conocimiento - prevención & control
Cognition Disorders - prevention & control
Esquema de Medicación
Drug Administration Schedule
Gliosis - prevención & control
Ratones Transgénicos
Mice, Transgenic
Trastornos del Humor - prevención & control
Mood Disorders - prevention & control
Proteínas del Tejido Nervioso - metabolismo
Nerve Tissue Proteins - metabolism
Neuroglía - patología
Neuroglia - pathology
Quercetina - uso terapéutico
Quercetin - therapeutic use
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
| Summary: | ABSTRACT: Alzheimer’s disease (AD) is the most common senile dementia in the world. Although important progress has been made in understanding the pathogenesis of AD, current therapeutic approaches provide only modest symptomatic relief. In this study, we evaluated the neuroprotective effect of quercetin (25 mg/kg) administration via i.p. injection every 48 hours for 3 months on aged (21–24 months old) triple transgenic AD model (3xTg-AD) mice. Our data show that quercetin decreases extracellular β-amyloidosis, tauopathy, astrogliosis and microgliosis in the hippocampus and the amygdala. These results were supported by a significant reduction in the paired helical filament (PHF), β-amyloid (βA) 1–40 and βA 1–42 levels and a decrease in BACE1-mediated cleavage of on learning and spatial elevated plus maze test. Together, these findings suggest that quercetin reverses histological hallmarks of AD and protects cognitive and emotional function in aged 3xTg-AD mice. |
|---|
